Towards Healthcare Research & Consulting

Biotechnology Product Manufacturing Companies and Organizational Growth Plans

Date : 30 March 2026

Who are the Biotechnology Product Manufacturing Market Top Vendors and What are Their Offerings?

Biotechnology Product Manufacturing Market Companies are Thermo Fisher Scientific, Sartorius, Danaher Corporation, Agilent Technologies, Illumina, Inc.

Take a look at the stats, segments, compititors and many more customized as per your business requirements.
Download the free sample today

Companies Headquarters Biotechnology Product Manufacturing Solutions
Thermo Fisher Scientific Waltham, U.S. Single-use bioreactors, chromatography systems, and mass spectrometers
Sartorius Gottingen, Germany Biostat STR bioreactors, membrane chromatography, and filtration units
Danaher Corporation Washington, U.S. Xcellerex bioreactors, centrifuges, and a protein purification system
Agilent Technologies Santa Clara, U.S. HPLC, mass spectrometry, and bioanalyzer
Illumina, Inc. San Diego, U.S. Next-generation sequencers and array-based platforms
Eppendorf SE Hamburg, Germany BioBLU single-use vessels, automated pipetting systems, and microcentrifuges
Bio-Rad Laboratories Hercules, U.S. Droplet Digital PCR, electrophoresis systems, and imaging tools
Waters Corporation Milford, U.S.  UPLC systems and mass spectrometry
Bruker Corporation Billerica, U.S. NMR spectrometers and mass spectrometry
Becton Dickinson (BD) Franklin Lakes, U.S. Flow cytometers and automated cell culture media systems

Biotechnology Product Manufacturing Market Value Chain Analysis

R&D

  • The R&D of the biotechnology product manufacturing focuses on automating bioprocesses and scaling single-use technologies for personalized medicines.
  • Key players: Thermo Fisher Scientific, Danaher Corporation, Sartorius.

Clinical Trials and Regulatory Approvals

  • The safety, manufacturing consistency, and efficiency of the biological products are evaluated in the clinical trials and regulatory approvals of the biotechnology product manufacturing.
  • Key players: Roche, Moderna, Pfizer.

Patient Support and Services

  • The financial assistance programs, digital adherence tools, and personalized nurse coaching are provided in the patient support and services of the biotechnology product manufacturing.
  • Key players: Amgen, AbbVie, Novartis.

Market Growth

The global biotechnology product manufacturing market size was estimated at USD 9.15 billion in 2025 and is predicted to increase from USD 10.39 billion in 2026 to approximately USD 32.61 billion by 2035, expanding at a CAGR of 13.55% from 2026 to 2035.

Biotechnology Product Manufacturing Market Size is USD 10.39 Billion in 2026.

The Pharmaceutical and Biotechnology Companies Segment Dominated the Market in 2025

Segment Share 2025 (%)
Pharmaceutical & Biotechnology Companies 40%
Hospitals and Clinics 20%
Research Institutions 18%
Diagnostic Laboratories 12%
Industrial Users 10%

Explanation

  • Pharmaceutical & Biotechnology Companies account for 40% of the market, leading due to their significant demand for chemical solutions in drug development and production.
  • Hospitals and Clinics represent 20% of the market, driven by their need for various medical products and treatments, but with a smaller share compared to pharmaceutical companies.
  • Research Institutions hold 18% of the market, playing a crucial role in advancing scientific studies and innovations, though not as dominant as pharmaceutical companies.
  • Diagnostic Laboratories make up 12% of the market, focusing on testing and diagnostics, contributing to healthcare but with a smaller share.
  • Industrial Users account for 10% of the market, using chemical products in manufacturing and industrial processes, yet holding the smallest share among the end-users.

The pharmaceutical and biotechnology companies segment held the largest revenue share of the market by 40% in 2025, due to growth in the production of vaccines, biologics, and other drugs. The growth in R&D activities, the launch of new products, and the growth in investments also increased the manufacturing process across these companies.

The hospitals and clinics segment is expected to show the highest growth during the predicted time, due to growing demand for new therapeutic, personalized treatments, and diagnostic options. The expanding healthcare infrastructures and growing disease burden are also increasing their adoption rates, propelling their manufacturing.

What are the Recent Developments in the Biotechnology Product Manufacturing Market?

  • In March 2026, to overcome the central challenge in cell therapy manufacturing that is scaling the adherent cell processes without introducing unnecessary complexity or compromising biology, the first system in the category of Dynamic Adherent Bioreactor, that is Archimedes® One, was launched by Green Elephant Biotech.
  • In September 2025, with an aim to enhance the time-to-market for biopharmaceutical companies with the use of an integrated and affordable ADC manufacturing and development platform, a collaboration between Mycenax Biotech Inc., and Spera Pharma Inc., was announced, where they will cover linker/payload synthesis, drug substance formulation, production, and aseptic fill-finish by offering turnkey solution for antibody-drug conjugates (ADCs) and bioconjugates.